Who invested in MapLight Therapeutics?
MapLight Therapeutics's investors include Novo Holdings, Sanofi, Blue Owl and 5AM Ventures.

United States · Funded startup
Funding summaryUpdated 26 Oct 2026
$523Mraised across 2 rounds since 2025, from 2 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Source recordedSEC filing: $188M sold, first sale Jul 2025
From MapLight Therapeutics's own website: 5 on the team.
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
MapLight Therapeutics's investors include Novo Holdings, Sanofi, Blue Owl and 5AM Ventures.
MapLight Therapeutics has raised $523M across 2 rounds since 2025.
MapLight Therapeutics's most recent round was an Undisclosed round of $150M in Aug 2026.
MapLight Therapeutics's largest round on record is $373M (Series D), in Jul 2025.
MapLight Therapeutics's first round on record, in Jul 2025, was backed by Novo Holdings, 5AM Ventures and Sanofi and 1 others.
MapLight Therapeutics's latest named round is an Undisclosed round, in Aug 2026.
MapLight Therapeutics is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.